Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

56.46
Delayed Data
As of Mar 03
 -0.70 / -1.22%
Today’s Change
47.36
Today|||52-Week Range
61.90
-1.83%
Year-to-Date

Today’s Trading

Previous close57.16
Today’s open56.82
Day’s range56.10 - 56.96
Volume3,170,546
Average volume (3 months)4,266,652
Market cap$54.7B
Dividend yield2.40%
Data as of 4:01pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)+136.23%
Earnings growth (this year)+1.35%
Earnings growth (next 5 years)+1.20%
Revenue growth (last year)-1.87%
P/E ratio20.3
Price/Sales2.45
Price/Book2.07

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc-0.07-0.30%
NEPTNeptune Technologies...+0.03+1.66%
VBLTVascular Biogenics L...-0.18-4.66%
Data as of 4:00pm ET, 03/03/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$1.25
Annual revenue (last year)$20.0B
Annual profit (last year)$3.0B
Net profit margin15.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account